5
Total deals
$1.3B
Total value
$316.2M
Avg deal
$500.0M
Largest
| # | Acquired | Date | Type | Status | Price | |
|---|---|---|---|---|---|---|
| 1 |
Just - Evotec Biologics
Designing innovative technologies focused on accelerating global access to bioth…
|
2025-07-30 | Acquisition | Pending | $300.0M | Deal → |
| 2 |
CIMERLI
CIMERLI is an interchangeable ranibizumab biosimilar vascular endothelial inhibi…
|
2024-01-22 | Acquisition | Complete | $170.0M | Deal → |
| 3 |
G
GSK - Cephalosporins Antibiotics Business
GlaxoSmithKline's Cephalosporins based brands composed of Zinnat, Zinacef and Fo…
|
2021-02-11 | Acquisition | Complete | $500.0M | Deal → |
| 4 |
Oriel Therapeutics
Oriel Therapeutics is a specialty pharmaceutical company developing and commerci…
|
2010-04-19 | Acquisition | Complete | — | Deal → |
| 5 |
G
Genetic Therapy
Genetic Therapy is a manufacturing company that specializes in providing product…
|
1995-07-11 | Acquisition | Complete | $295.0M | Deal → |